Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 11 of about 6 companies and 5 funds for Jeffrey Reed�
Company Exchange Symbol Last price Quote change Market cap
Intrexon Corp NYSE XON 29.67 -0.72 (-2.37%) 3.36B
Intrexon Corporation is engaged in the field of synthetic biology. The Company designs, builds and regulates gene programs, which are Deoxyribonucleic Acid ...
Executive:
Jeffrey B. Kindler
Almost Family Inc NASDAQ AFAM 36.16 +0.83 (2.35%) 352.41M
Almost Family, Inc., along with its subsidiaries, is a provider of home health services. The Company has two divisions, Home Health Care and Healthcare ...
Executive:
Jeffrey T. Reibel CPA
Celladon Corp NASDAQ CLDN 0.898 -0.012 (-1.30%) 19.16M
Celladon Corporation (Celladon) is a clinical-stage biotechnology company engaged in the development of cardiovascular gene therapy.
Executive:
Jeffrey J. Rudy
Codorus Valley Bancorp, Inc. NASDAQ CVLY 19.90 +0.09 (0.45%) 152.43M
Codorus Valley Bancorp Inc. (Codorus Valley) is a bank holding company. The Company's wholly owned bank subsidiary is PeoplesBank, A Codorus Valley Company ...
Executive:
Jeffrey R.
Webco Industries, Inc. OTCMKTS WEBC 33.50 0.00 (0.00%) 41.63M
Webco Industries, Inc. is a manufacturer and value added distributor of carbon steel, stainless steel and other metal tubular products designed to industry ...
Executive:
Jeffrey W. Williams
InVitro International OTCMKTS IVRO 0.0155 0.0000 (0.00%) 348,456.00
Invitro International is a customer and technology driven provider of non-animal testing methods. The Company develops and commercializes globally both test ...
Executive:
Jeffrey A. Safchik
Mutual Fund Symbol Nav Nav change
Consulting Group Large Cap Value Equity Fund TLVUX 11.01 -0.12 (-1.06%)
The investment seeks total return, consisting of capital appreciation and dividend income. The fund normally invests at least 80% of its net assets (plus ...
Executive:
Jeffrey H.
Virtus Alternative Total Solution Fund Class C VATCX 8.30 +0.03 (0.36%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
Jeffrey A. Altman
Virtus Alternative Total Solution Fund Class A VATAX 8.34 +0.03 (0.36%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
Jeffrey A. Altman
Virtus Alternative Total Solution Fund Class I VATIX 8.36 +0.04 (0.48%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
Jeffrey A. Altman
Virtus Alternative Total Solution Fund Class R6 VATRX 8.36 +0.03 (0.36%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
Jeffrey A. Altman